3 Year Absolute Returns
72.86% ↑
NAV (₹) on 16 Nov 2026
20.47
1 Day NAV Change
-0.43%
Risk Level
Very High Risk
Rating
-
ITI Pharma and Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by ITI Asset Management Limited. Launched on 18 Oct 2021, investors can start with a minimum SIP ... Read more
AUM
₹ 266.72 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 75.68% |
| Hospitals & Medical Services | 19.74% |
| Medical Equipment & Accessories | 1.28% |
| Plastics - Plastic & Plastic Products | 1.26% |
| Net Receivables/(Payables) | 1.22% |
| Industrial Gases | 0.82% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 11.67% | ₹ 31.14 | Pharmaceuticals |
| Divi's Laboratories Limited | 9.98% | ₹ 26.63 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 5.62% | ₹ 14.99 | Hospitals & Medical Services |
| Dr. Reddy's Laboratories Limited | 5.23% | ₹ 13.95 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 4.58% | ₹ 12.21 | Pharmaceuticals |
| Laurus Labs Limited | 4.54% | ₹ 12.10 | Pharmaceuticals |
| Cipla Limited | 4.28% | ₹ 11.41 | Pharmaceuticals |
| Max Healthcare Institute Limited | 4.14% | ₹ 11.04 | Hospitals & Medical Services |
| Aurobindo Pharma Limited | 4.03% | ₹ 10.74 | Pharmaceuticals |
| Mankind Pharma Limited | 3.75% | ₹ 10.01 | Pharmaceuticals |
| Cohance Lifesciences Limited | 3.13% | ₹ 8.35 | Pharmaceuticals |
| Alkem Laboratories Limited | 3.05% | ₹ 8.14 | Pharmaceuticals |
| Fortis Healthcare Limited | 2.96% | ₹ 7.89 | Hospitals & Medical Services |
| Neuland Laboratories Limited | 2.73% | ₹ 7.29 | Pharmaceuticals |
| Global Health Limited | 2.65% | ₹ 7.07 | Hospitals & Medical Services |
| Lupin Limited | 2.02% | ₹ 5.38 | Pharmaceuticals |
| Abbott India Limited | 2.02% | ₹ 5.39 | Pharmaceuticals |
| IPCA Laboratories Limited | 1.94% | ₹ 5.17 | Pharmaceuticals |
| Sai Life Sciences Limited | 1.90% | ₹ 5.08 | Pharmaceuticals |
| Aster DM Quality Care Limited | 1.65% | ₹ 4.41 | Hospitals & Medical Services |
| Gland Pharma Limited | 1.50% | ₹ 4.01 | Pharmaceuticals |
| Shilpa Medicare Limited | 1.29% | ₹ 3.43 | Pharmaceuticals |
| Poly Medicure Limited | 1.28% | ₹ 3.41 | Medical Equipment & Accessories |
| Shaily Engineering Plastics Limited | 1.26% | ₹ 3.35 | Plastics - Plastic & Plastic Products |
| Piramal Pharma Limited | 1.23% | ₹ 3.29 | Pharmaceuticals |
| Net Receivables / (Payables) | 1.22% | ₹ 3.22 | Others |
| Anthem Biosciences Limited | 1.20% | ₹ 3.20 | Pharmaceuticals |
| Glenmark Pharmaceuticals Limited | 1.11% | ₹ 2.95 | Pharmaceuticals |
| Rainbow Childrens Medicare Limited | 0.92% | ₹ 2.46 | Hospitals & Medical Services |
| Metropolis Healthcare Limited | 0.91% | ₹ 2.43 | Hospitals & Medical Services |
| Healthcare Global Enterprises Limited | 0.89% | ₹ 2.38 | Hospitals & Medical Services |
| Supriya Lifescience Limited | 0.89% | ₹ 2.37 | Pharmaceuticals |
| GlaxoSmithKline Pharmaceuticals Limited | 0.86% | ₹ 2.30 | Pharmaceuticals |
| Linde India Limited | 0.82% | ₹ 2.19 | Industrial Gases |
| Zydus Lifesciences Limited | 0.78% | ₹ 2.09 | Pharmaceuticals |
| Biocon Limited | 0.77% | ₹ 2.06 | Pharmaceuticals |
| Syngene International Limited | 0.62% | ₹ 1.66 | Pharmaceuticals |
| Caplin Point Laboratories Limited | 0.58% | ₹ 1.56 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 23.83% | 16.14% | 8.07% | 20.01% |
| Category returns | 7.37% | 5.10% | 9.83% | 22.69% |
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹23.46 | 30.32% | 124.36% | 0.00% | ₹3,666 | 1.03% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹37.89 | 18.16% | 76.07% | 123.95% | ₹3,597 | 0.86% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹20.47 | 16.15% | 72.88% | 104.34% | ₹267 | 0.92% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹20.47 | 16.14% | 72.86% | 104.32% | ₹267 | 0.92% |
Very High
|
|
ITI Flexi Cap Fund - Direct Plan
Diversified
Direct
|
₹22.04 | 15.22% | 68.48% | 0.00% | ₹1,621 | 0.91% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹33.49 | 16.49% | 68.12% | 105.72% | ₹3,597 | 2.22% |
Very High
|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹35.92 | 15.78% | 66.91% | 112.30% | ₹3,597 | 0.86% |
Very High
|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹35.92 | 15.78% | 66.91% | 112.30% | ₹3,597 | 0.86% |
Very High
|
|
ITI Pharma and Healthcare Fund
Sector
Regular
|
₹18.54 | 14.09% | 63.53% | 85.14% | ₹267 | 2.62% |
Very High
|
|
ITI Pharma and Healthcare Fund
Sector
Regular
|
₹18.54 | 14.09% | 63.53% | 85.14% | ₹267 | 2.62% |
Very High
|
|
ITI Pharma and Healthcare Fund
Sector
Regular
|
₹18.54 | 14.09% | 63.53% | 85.14% | ₹267 | 2.62% |
Very High
|
What is the current NAV of ITI Pharma and Healthcare Fund - Direct Plan IDCW?
What is the fund size (AUM) of ITI Pharma and Healthcare Fund - Direct Plan IDCW?
What are the historical returns of ITI Pharma and Healthcare Fund - Direct Plan IDCW?
What is the risk level of ITI Pharma and Healthcare Fund - Direct Plan IDCW?
What is the minimum investment amount for ITI Pharma and Healthcare Fund - Direct Plan IDCW?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article